We detected more Tie2+Iba1+ cells at the tumor edge in brains of mice treated with aflibercept during 6 weeks or bevacizumab (invasive pattern) than in mice treated with hFc, 3-week aflibercept, or TMZ (non-invasive pattern) (Figure 2B-E). The gene discussed is TEK; the disease is neoplasm.